AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 52 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,820,308 | -23.2% | 833,927 | +11.5% | 3.28% | -11.0% |
| Q4 2022 | $21,912,562 | +58.5% | 747,869 | -10.3% | 3.69% | +73.0% |
| Q3 2022 | $13,827,000 | +49.8% | 833,927 | +41.2% | 2.13% | +17.4% |
| Q2 2022 | $9,228,000 | +233.3% | 590,408 | +290.9% | 1.82% | +304.7% |
| Q1 2022 | $2,769,000 | – | 151,037 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |